BIIB021
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BIIB021, covering 2009-07-14 to 2016-12-29. Get the full timeline:
Most recent: Clinical Trial Update: Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors [Phase 1]